Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension ; day:07 ; month:08 ; year:2021 ; extent:15
Advanced science ; (07.08.2021) (gesamt 15)
- Urheber
-
Jin, Seung Mo
Lee, Sang Nam
Kim, Jung Eun
Yoo, Yeon Jeong
Song, Chanyoung
Shin, Hong Sik
Phuengkham, Hathaichanok
Lee, Chang Hoon
Um, Soong Ho
Lim, Yong Taik
- DOI
-
10.1002/advs.202102043
- URN
-
urn:nbn:de:101:1-2021080715245689401505
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jin, Seung Mo
- Lee, Sang Nam
- Kim, Jung Eun
- Yoo, Yeon Jeong
- Song, Chanyoung
- Shin, Hong Sik
- Phuengkham, Hathaichanok
- Lee, Chang Hoon
- Um, Soong Ho
- Lim, Yong Taik
Ähnliche Objekte (12)
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization
Chemical immunosuppression
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
Immunosuppression by cytostatic drugs?
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization
Chemical immunosuppression
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
Immunosuppression by cytostatic drugs?
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization
Chemical immunosuppression
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy